Business, Policy & Funding
Breaking news on Diagnostics business, policy & funding.
Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership
The complaint focuses on a recent patent filed by Chunxiao Song, the consultant, alleging that it falls within the terms of his contract with Bluestar.Â
In Brief This Week: OpGen, Yale School of Public Health, ProPhase Labs, Core Diagnostics, and More
News items for the in vitro diagnostics industry for the week of June 7, 2021.
Avacta Obtains CE Mark for SARS-CoV-2 Antigen Test
The firm said it has ongoing commercial discussions for its lateral flow antigen test with distributors and end users in countries that accept the CE mark.
Lucid Diagnostics Obtains CE Mark for Esophageal Cancer Molecular Test
Lucid said that key opinion leaders for esophageal disease in Europe are participating in pivotal clinical trials for the test and its collection device.
FDA Warns Against Use of Innova Medical Group SARS-CoV-2 Antigen Test
Innova had been selling the test in the US despite never having received marketing approval, clearance, or authorization, according to the FDA.
Jun 10, 2021
LetsGetChecked Closes $150M Funding Round
Jun 8, 2021
Oncimmune Reports Jump in Fiscal 2021 Revenues
Jun 4, 2021